Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization

INTRODUCTION: Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator that has demonstrated clinical benefits in phase 3 trials. We report results from a real-world study (BRIO) to assess the effectiveness of ivacaftor in people with cystic fibrosis (pwCF) in France. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hubert, Dominique, Marguet, Christophe, Benichou, Jacques, DeSouza, Cynthia, Payen-Champenois, Catherine, Kinnman, Nils, Chandarana, Keval, Munck, Anne, Fajac, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589905/
https://www.ncbi.nlm.nih.gov/pubmed/34101145
http://dx.doi.org/10.1007/s41030-021-00158-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589905/
https://www.ncbi.nlm.nih.gov/pubmed/34101145
http://dx.doi.org/10.1007/s41030-021-00158-5

Ejemplares similares